Alliance Dermatology & Mohs Center

1. AbbVie, Inc. $609,928 150 payments
2. Biofrontera Bioscience GmbH $237,680 8 payments
3. Sun Pharmaceutical Industries Inc. $78,121 18 payments
4. Biofrontera Inc. $59,109 10 payments
5. Mindera Corp $40,109 9 payments
6. Amgen Inc. $34,473 2 payments
7. Bausch Health US, LLC $953 1 payment

1. Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis $144,824 23 payments
2. Ala-Ak-Ct018 $104,866 3 payments
3. Ala-Bcc-Ct013 $104,248 3 payments
4. Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) $87,314 30 payments
5. Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata $75,621 15 payments
6. A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo (Viti-Up) $61,984 15 payments
7. Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy $54,453 13 payments
8. A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) $49,897 11 payments
9. Study to Evaluate the Safety, Tolerability and Efficacy of Bf-200 Ala (Ameluz) in the Field-Directed Treatment of Actinic Keratosis (Ak) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using A Rhodoled Lamp $45,231 4 payments
10. A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis $33,980 12 payments

1. Patient care $40,109 9 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.